The decision to learn one’s own genetic risk for developing FTD is highly personal. An individual’s test results may reveal information not only about their own status, but may shed light on other family members’ risk for developing FTD. But many current FTD studies and clinical trials require participants with specific genes. Now more than ever, individuals need to carefully consider their options and weigh the opportunities to access experimental treatments, the personal impact of results, and how one’s results may affect other family members. During this one-hour webinar, members of the AFTD community share their personal experiences with genetic FTD, and what factors most influenced their genetic-testing decisions.